Enzo Biochem, Inc. (ENZ) delivered a loss per share of 4 cents from continuing operations in the third quarter of fiscal 2024, narrower than the year-ago quarter's loss of 16 cents per share. Geographic Details The Asia Pacific segment generated revenues of $0.9 million, up 15.4$4.5 million. Research and development expenses decreased 31.6% year over year to $0.6 million. Adjusted operating expenses of$5.1 million ...